Literature DB >> 23492553

Physical exercise and Parkinson's disease: influence on symptoms, disease course and prevention.

Rita Grazina1, João Massano.   

Abstract

Parkinson's disease (PD) is a common, disabling, neurodegenerative condition, and the disease prevalence is expected to increase worldwide in the next few decades. Symptomatic therapy remains unsatisfactory, and greatly needed neuroprotective therapies have not been successfully developed so far. Physical exercise (PE) has been associated with a lower risk of developing a neurodegenerative disease. The literature has been searched, and results have been systematized and interpreted with regard to the effects of PE in PD. Published data show the following: 1) PE has been associated with a lower risk of developing PD; 2) PE has been shown to improve disease symptoms, mobility, balance, gait and quality of life (in this regard, walking training, tai-chi and tango dancing have demonstrated the highest level of evidence of efficacy); and 3) neuroprotective effects from PE could be expected in PD, although this has been suggested in animal studies only. Further research on this topic should be encouraged. Multidisciplinary cooperation between neurologists, sports physicians and researchers is paramount.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23492553     DOI: 10.1515/revneuro-2012-0087

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  19 in total

Review 1.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

Review 2.  Impacts of dance on non-motor symptoms, participation, and quality of life in Parkinson disease and healthy older adults.

Authors:  M E McNeely; R P Duncan; G M Earhart
Journal:  Maturitas       Date:  2015-08-12       Impact factor: 4.342

3.  Dynamics of change in self-reported disability among persons with Parkinson's disease after 2 years of follow-up.

Authors:  Tatjana Gazibara; Darija Kisic-Tepavcevic; Marina Svetel; Aleksandra Tomic; Iva Stankovic; Vladimir Kostic; Tatjana Pekmezovic
Journal:  Neurol Sci       Date:  2017-05-13       Impact factor: 3.307

Review 4.  Schizophrenia as a disorder of molecular pathways.

Authors:  Szatmár Horváth; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2014-01-10       Impact factor: 13.382

5.  Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

Authors:  Joan A O'Keefe; Erin Robertson-Dick; Emily J Dunn; Yan Li; Youping Deng; Amber N Fiutko; Elizabeth Berry-Kravis; Deborah A Hall
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

6.  So much research, so little application: Barriers to dissemination and practical implementation of Tai Ji Quan.

Authors:  Peter A Harmer
Journal:  J Sport Health Sci       Date:  2014-03-01       Impact factor: 7.179

7.  Do Acute Exercise-Induced Activations of the Kynurenine Pathway Induce Regulatory T-Cells on the Long-Term? - A Theoretical Frame Work Supported by Pilot Data.

Authors:  Christina Koliamitra; Florian Javelle; Niklas Joisten; Alexander Shimabukuro-Vornhagen; Wilhelm Bloch; Alexander Schenk; Philipp Zimmer
Journal:  J Sports Sci Med       Date:  2019-11-19       Impact factor: 2.988

8.  Exercise Therapy for a Patient With Parkinson Disease and Back Pain: A Case Report.

Authors:  Christina L Rosarion
Journal:  J Chiropr Med       Date:  2018-03-01

Review 9.  Use it and boost it with physical and mental activity.

Authors:  Donna L Korol; Paul E Gold; Claire J Scavuzzo
Journal:  Hippocampus       Date:  2013-11       Impact factor: 3.899

Review 10.  Road to exercise mimetics: targeting nuclear receptors in skeletal muscle.

Authors:  Weiwei Fan; Annette R Atkins; Ruth T Yu; Michael Downes; Ronald M Evans
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.